New research indicates that individuals who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop traditional lifestyle plans.
Findings released in a prominent health publication demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"People using such medications need to be informed of the potential of fast rebound weight gain when the treatment concludes," cautioned expert Dr. Susan Jebb.
Such speed of regain implies a return to original mass in about 18 months.
Analyzing Approaches
The study, which looked at dozens of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with conventional dieting.
Researchers note that individuals who lose weight through dieting generally experience a less rapid creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Regain
Experts propose the mechanism of the jabs is key to understanding the heightened regain.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 concentrations several times higher than normal might result in the body to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication results in appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, given the likelihood of weight regain, the treatment is often long-term.
This view is supported by drug manufacturers, who say that the findings "highlight the long-term character of obesity," akin to managing diseases like high blood pressure.
Patient Experiences
Individuals who have stopped the jabs explain a sudden return of appetite.
"It was like a switch activating and you become ravenous," recalled a patient.
This challenge is worsened if users have not adopted lasting lifestyle or habit modifications during therapy.
Growing Adoption
Figures indicate that millions of people in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is higher among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while these medications are powerful agents for weight loss, they are not a magic fix and long-term success hinges on ongoing lifestyle management.
